Watch the success stories by Professor Marianna Fontana and Christine Chiti from the National Amyloidosis Centre Royal Free Hospital in London.
Amyloidosis is a complex disease encompassing various subtypes. It places a significant burden on patients and healthcare systems worldwide.
Amyloidosis is a complex disease encompassing various subtypes. It places a significant burden on patients and healthcare systems worldwide.
Delayed diagnoses are common, and patients can face a grim prognosis with the risk of death within 3 months to 15 years without treatment, depending on the subtype of amyloidosis.
To learn more about the full program, visit pbc.ime.springerhealthcare.com
---
AstraZeneca and Alexion, AstraZeneca Rare Disease have provided an unrestricted educational grant towards this independent program.
Delayed diagnoses are common, and patients can face a grim prognosis with the risk of death within 3 months to 15 years without treatment, depending on the subtype of amyloidosis.